Deciphering the role of IL-17D, its newly identified receptor CD93, and IL-17D-CD93 axis in health and disease
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf061 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Kexin Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Interleukin-17, Receptors, Complement, Membrane Glycoproteins. Die Arbeit nennt 105 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Key Research and Development Support Project of Science and Technology Department of Chengdu.
Abstract (Originalsprache)
This review explores interleukin (IL)-17D and its receptor CD93, highlighting their structural, functional, and clinical aspects. Identifying CD93 as the receptor for IL-17D has advanced understanding of the IL-17 family and its signaling pathways. IL-17D, with its unique glycoprotein structure, plays diverse roles in oxidative stress response and potential antitumor therapies. It is involved in autoimmune diseases, infections, and cancers, making it a promising therapeutic target. CD93 is crucial in various biological processes, from angiogenesis to inflammatory diseases. CD93's implications in cancers, neuroinflammation, and metabolism highlight its significance as a potential prognostic marker and therapeutic target. The review emphasizes IL-17D and CD93 as promising areas for future research, offering insights into their signaling pathways and potential applications in personalized medicine. Deciphering the relationship between IL-17D and CD93 is in its infancy and invites exploration for transformative advancements in immunology and beyond.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
- Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, China.
- Cardiac Structure and Function Research Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China.
- West China School of Medicine, Sichuan University, Chengdu, China.
- Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Kexin Jiang, Yanjiani Xu, Nanhao Yin, Fangyang Huang, Mao Chen
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Key Research and Development Support Project of Science and Technology Department of Chengdu
- Chinese Medical Association Cardiovascular Branch
- Clinical Research Special Fund
- West China Hospital
- West China Hospital of Sichuan University
Zitieren
APA
Jiang, K., Xu, Y., Wang, Y., Yin, N., Huang, F., & Chen, M. (2025). Deciphering the role of IL-17D, its newly identified receptor CD93, and IL-17D-CD93 axis in health and disease. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf061
Vancouver
Jiang K, Xu Y, Wang Y, Yin N, Huang F, Chen M. Deciphering the role of IL-17D, its newly identified receptor CD93, and IL-17D-CD93 axis in health and disease. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf061
BibTeX
@article{Jiang2025,
author = {Jiang, Kexin and Xu, Yanjiani and Wang, Yan and Yin, Nanhao and Huang, Fangyang and Chen, Mao},
title = {Deciphering the role of IL-17D, its newly identified receptor CD93, and IL-17D-CD93 axis in health and disease},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf061}
}
EUVIMED